| Serial Number | 88096818 |
| Word Mark | DRASC |
| Filing Date | Wednesday, August 29, 2018 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, February 16, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 19, 2019 |
| Goods and Services | Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Software as a service (SAAS) services featuring software for precision oncology drug library screening; Product research and development, namely, testing of the newest drugs through high-throughput smart-screening platform to determine the best pharmacological treatments for an individual patient; Pharmacological product research consultation services that will enable others, namely, doctors and clinicians, to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing |
| Goods and Services | Medical testing for diagnostic or treatment purposes; Providing cancer screening services; Genetic counseling; Genetic testing for medical purposes; Health care services for treating cancer; Medical analysis services for the diagnosis of cancer; Providing personalized healthcare and medical information in the nature of providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing, individual behaviors including medication compliance, exercise, diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 7, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, September 16, 2019 |
| First Use In Commerce Date | Monday, September 16, 2019 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 7, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | Monday, September 16, 2019 |
| First Use In Commerce Date | Monday, September 16, 2019 |
| Party Name | AccuBeing, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Chapel Hill, NC 27514 |
| Party Name | AccuBeing, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Chapel Hill, NC 27514 |
| Event Date | Event Description |
| Tuesday, February 16, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, February 16, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, August 3, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, August 3, 2020 | FINAL REFUSAL E-MAILED |
| Monday, August 3, 2020 | SU - FINAL REFUSAL - WRITTEN |
| Wednesday, July 29, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 28, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 28, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 28, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 28, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 28, 2020 | SU - NON-FINAL ACTION - WRITTEN |
| Thursday, April 9, 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, March 24, 2020 | USE AMENDMENT FILED |
| Thursday, April 9, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, March 24, 2020 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, August 28, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 26, 2019 | EXTENSION 1 GRANTED |
| Monday, August 26, 2019 | EXTENSION 1 FILED |
| Monday, August 26, 2019 | TEAS EXTENSION RECEIVED |
| Tuesday, April 16, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 19, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 19, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 30, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 11, 2019 | ASSIGNED TO LIE |
| Tuesday, December 18, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, December 17, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 17, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 17, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 12, 2018 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Wednesday, December 12, 2018 | PRIORITY ACTION E-MAILED |
| Wednesday, December 12, 2018 | PRIORITY ACTION WRITTEN |
| Wednesday, December 12, 2018 | ASSIGNED TO EXAMINER |
| Friday, September 7, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, September 1, 2018 | NEW APPLICATION ENTERED IN TRAM |